Rituxan (rituximab) - Roche
doxorubicin hydrochloride - Generic mfg.
vincristine - Generic mfg.
cyclophosphamide - Generic mfg.
prednisone - Generic mfg.
A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma (clinicaltrials.gov) - Oct 13, 2026 - P2 | N=40 | Recruiting | Sponsor: University of Rochester | Trial primary completion date: Jun 2026 ➔ Dec 2026 
Trial primary completion date • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
http://clinicaltrials.gov/ct2/show/NCT03758989
 
Oct 13, 2026
 
Prev Next